计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
Moligand™ 级 提供 ≥98% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
2-8°C储存。低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 83 篇同行评审文献引用。
Diclofenac is a non-selective COX inhibitor with IC50 of 60 and 220 nM for ovine COX-1 and -2, respectively. Target: COX Diclofenac is a nonsteroidal anti-inflammatory drμg (NSAID) taken or applied to reduce inflammation and as an analgesic reducing pain in certain conditions. The primary mechanism responsible for its anti-inflammatory, antipyretic, and analgesic action is thoμght to be inhibition of prostaglandin synthesis by inhibition of cyclooxygenase (COX). It also appears to exhibit bacteriostatic activity by inhibiting bacterial DNA synthesis. Inhibition of COX also decreases prostaglandins in the epithelium of the stomach, making it more sensitive to corrosion by gastric acid. This is also the main side effect of diclofenac. Diclofenac has a low to moderate preference to block the COX2-isoenzyme and is said to have, therefore, a somewhat lower incidence of gastrointestinal complaints than noted with indomethacin and aspirin.
Diclofenac (双氯芬酸) 是COX抑制剂,对绵羊的COX-1和-2的IC50分别为60和220 nM。
Diclofenac is a non-selective COX inhibitor with IC50 of 60 and 220 nM for ovine COX-1 and -2, respectively. Target: COX Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) taken or applied to reduce inflammation and as an analgesic reducing pain in certain conditions. The primary mechanism responsible for its anti-inflammatory, antipyretic, and analgesic action is thought to be inhibition of prostaglandin synthesis by inhibition of cyclooxygenase (COX). It also appears to exhibit bacteriostatic activity by inhibiting bacterial DNA synthesis. Inhibition of COX also decreases prostaglandins in the epithelium of the stomach, making it more sensitive to corrosion by gastric acid. This is also the main side effect of diclofenac. Diclofenac has a low to moderate preference to block the COX2-isoenzyme and is said to have, therefore, a somewhat lower incidence of gastrointestinal complaints than noted with indomethacin and aspirin.
Diclofenac acid is a nonsteroidal anti-inflammatory compound and decycloxygenase (COX) inhibitor.
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 苯类化合物 |
| 类(Class) | 苯及其取代衍生物 |
| 亚类(Subclass) | 卤代苯 |
| 中间层级节点(Intermediate Tree Nodes) | 氯苯类 |
| 直接上位类(Direct Parent) | 二氯苯 |
| 其他上位类(Alternative Parents) | 苯胺和取代苯胺 芳基氯化物 氨基酸 仲胺 一元羧酸及其衍生物 羧酸 有机光子化合物 有机氯化物 有机氧化物 碳氢化合物衍生物 羰基化合物 |
| 分子骨架(Molecular Framework) | 芳香族同单环化合物 |
| 取代基(Substituents) | 1,3-二氯苯 - 氨基酸 - 氨基酸 - 氨基酸或其衍生物 - 苯胺或取代苯胺 - 芳香族同单环化合物 - 芳基氯化物 - 芳基卤化物 - 羰基 - 羧酰胺基 - 羧酸衍生物 - 烃衍生物 - 单羧酸或其衍生物 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机氯化物 - 有机卤化物 - 有机氮化合物 - 有机氧化合物 - 有机氮化合物 - 醛基 |
| 描述(Description) | 该化合物属于二氯苯类有机化合物。这类化合物包含一个苯环,其上恰好连接两个氯原子。 |
| 外部描述符(External Descriptors) | monocarboxylic acid - secondary amino compound - dichlorobenzene - aromatic amine - amino acid |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
H301: 吞咽会中毒
H361: 怀疑破坏生育力或未出生的孩子
H372: 通过长时间或反复暴露对器官造成损害
H411: 对水生生物有毒并具有长期持续影响
P201: 使用前获取特殊说明
P202: 在阅读并理解所有安全预防措施之前,不要进行操作。
P260: 不要吸入灰尘/烟雾/气体/雾/蒸汽/喷雾。
P264: 处理后要彻底洗手。
P270: 使用本产品时,请勿进食、饮水或吸烟。
P273: 避免释放到环境中。
P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。
P391: 收集溢出物
P308+P313: 如接触到或有疑虑:求医/就诊。
P405: 密闭存放
P501: 将内容物/容器处理到。。。
P301+P312+P330: 如误吞咽:如感觉不适,呼叫急救中心/医生。漱口
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 | |
| 分析证书 | D155733 |